Binet Staging System for CLL
Classifies CLL by the number of involved lymphoid regions and by whether anemia or thrombocytopenia is present.
Areas of lymphadenopathy
< 3+1≥ 3+2
Anemia (Hgb < 10 g/dL)
No0Yes+3
Thrombocytopenia (plts < 100,000/mm^3)
No0Yes+3
Indications for Use
Stratifies newly diagnosed CLL into A, B, C using hemoglobin, platelets, and number of involved lymphoid areas.
Insights & Cautions
Starts with grouping patients into A (favorable), B (intermediate), and C (advanced), based on cytopenias and number of involved lymphoid areas.
- Strengths: Simple bedside tool; reliably separates broad prognostic groups 1 [Level III evidence].
- Cautions: Limited precision in the era of targeted agents; does not account for IGHV, TP53, or cytogenetics, which strongly influence outcomes 2 [Level II evidence].
- Implication: Useful for treatment indication, but insufficient alone for prognostication.